“We are happy to announce that we are adding three new doctors in Texas to our iUGO Care platform, ”said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “These primary care physician offices use our iUGO Care Remote Patient Monitoring (RPM), Chronic Care Behavioral Health Integration (BHI) Management Modules (CCM). We expect to embed more than 1,500 patients with these clients on average income of US $ 60 per patient per month. Integration with the three clients will begin this month and is expected to be completed later this quarter. “
“We have seen a significant increase in demand for our solutions in Texas in response to the new Texas Medicaid guidelines that came into effect on September 1, 2021,” continued Dr. Crossley. “Under the new guidelines, Texas Medicaid has expanded the clinical conditions eligible for reimbursement for remote monitoring of patients to include congestive heart failure, terminal solid organ disease (heart, liver, kidney, lung, pancreas ), organ transplants and conditions requiring mechanical intervention. ventilation. While the federal Medicare program already included these conditions and several others, Texas Medicaid previously only covered remote monitoring of patients with hypertension and diabetes. The recent expansion of the Texas Medicaid remote patient monitoring program is in line with trends we have seen in the U.S. healthcare market to increase both the available reimbursement amounts and the reach of virtual patient care programs. with chronic diseases. emergencies and intensive care by proactively managing their conditions using virtual care. There is a real sense of urgency among our clients to get their patients on board quickly to help them stay healthy and at home during what most healthcare professionals expect will be a fall and a year. very difficult winters for hospitals due to the combined threat of the Delta variant and the flu. season. Using iUGO Care dramatically reduces the risk of hospitalization due to complications typically seen in chronically ill patients, helping to prevent these patients from adding strain to an already overburdened acute care system. ”
Reliq Health Technologies is a growing global telemedicine company specializing in the development of innovative virtual care solutions for the multi-billion dollar healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care enables complex patients to receive high quality care at home, improving health outcomes, improving the quality of life for patients and families, and reducing the cost of providing care. iUGO Care provides real-time access to remote patient monitoring data, enabling the healthcare team to intervene in a timely manner to avoid costly hospital readmissions and emergency room visits. Reliq Health Technologies trades on the TSX Venture Exchange under the symbol RHT, on the OTC under the name RQHTF and on the WKN under the name A2AJTB.
ON BEHALF OF THE BOARD
“Dr Lisa Crossley”
CEO and director
For more information please contact:
Investor Relations at [email protected]
Contact for U.S. Investor Relations
Lytham Partners, LLC
New York | Phoenix
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautions Regarding Forward-Looking Information
Certain statements contained in this press release constitute forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including, but not limited to, statements regarding estimates, plans, programs, forecasts, projections, goals, assumptions, expectations or beliefs regarding future performance, are “forward-looking statements”.
We caution you that these “forward-looking statements” involve known and unknown risks and uncertainties which could cause actual and future events to differ materially from those anticipated in such statements.
Forward-looking statements include, without limitation, statements regarding business operations, including technological development, anticipated revenues, projected market size and other information based on forecasts of future results, estimates of amounts not yet determinable and management assumptions.
Reliq Health Technologies Inc. (the “Society“) does not intend and assumes no obligation to update these forward-looking statements, except as required by law. These forward-looking statements involve risks and uncertainties relating, among other things, to technological development activities and marketing, historical activities of the Company technological development experience, uninsured risks Actual results may differ materially from those expressed or implied by these forward-looking statements.
SOURCE: Reliq Health Technologies Inc.